Omega-3 claims petition
This article was originally published in The Tan Sheet
FDA has filed health claim petition "for conventional foods and dietary supplements relating consumption of omega-3 fatty acids...to reduced risk of coronary heart disease," agency states in Sept. 3 letter to Washington, D.C. law firm Emord & Associates. Emord submitted petition June 23 on behalf of Wellness Lifestyles, Inc., and Life Extension Foundation Buyers Club (1"The Tan Sheet" June 30, 2003, p. 11). Petition is posted on FDA 2website, with open comment period until Nov. 2. Agency will notify petitioners of final decision by April 15, 2004...
You may also be interested in...
FDA should amend the approved health claim linking omega-3 fatty acids to a reduced risk of coronary heart disease by removing the disclaimer and extending the claim to foods, supplement industry members maintain in a June 23 petition
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.